Albemarle Corporation(ALB) Stock Research - Grey Stern Research

Albemarle Corporation (ALB) Stock Analysis

$89.33 (3.16%)

ALB Financial Performance


Use the table below to view Albemarle Corporation's financial profile. This data is gathers from the latest available financial statements. Annual data is taken from the trailing 12 months of statements. All numbers are reported in US Dollars and so any foreign currencies are converted to USD so comparison's can be done.

Based on Financial Statements from Q2 - 2024

Metric Value Ranking among Peers
Price $86.59 -
52 Week Low $71.97 -
52 Week High $181.48 -
Market Cap $10.2 Billion 9/11
Gross Margin -1% 10/11
Profit Margin -13% 10/11
EBITDA margin -4% 9/11
Q2 - 2024 Revenue $1.4 Billion 7/11
Q2 - 2024 Earnings -$188.2 Million 11/11
Q2 - 2024 Free Cash Flow -$84.7 Million 10/11
Trailing 4 Quarters Revenue $7.5 Billion 8/11
Trailing 4 Quarters Earnings -$500.9 Million 11/11
Quarterly Earnings Growth -129% 11/11
Annual Earnings Growth -115% 11/11
Quarterly Revenue Growth -40% 10/11
Annual Revenue Growth -26% 10/11
Cash On Hand $1.8 Billion 3/11
Short Term Debt $31.6 Million 8/11
Long Term Debt $3.4 Billion 8/11

Albemarle Corporation Financial Metrics


Financial metrics are a set of useful numbers that can give key performance indicators of a company. The various metrics can include information about profitability, growth, and debt load. When combined and use properly they can tell an analyst a compelling fact-based story of how the company is currently performing. To compare Albemarle Corporation's metrics versus it's peers make sure to run our peer analysis tool.

Valuation Metrics

Metric Value Ranking among Peers
PE -1.00 10/11
PS 1.36 10/11
PB 0.89 9/11
PC 5.56 9/11
Liabilities to Equity 0.62 8/11
ROA -0.03 10/11
ROE -0.04 10/11
Current Ratio 2.66 4/11
Quick Ratio 0.27 3/11
Long Term Debt to Equity 0.30 9/11
Debt to Equity 0.33 8/11
Burn Rate 5.50 5/11
Cash to Cap 0.18 2/11
CCR 0.45 8/11
EV to EBITDA -227.35 11/11
EV to Revenue 1.61 10/11

Company Details

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine segment offers bromine and bromine-based fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines for surfactants, biocides, and disinfectants and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.

CEO: Mr. Luther Kissam

Website: https://www.albemarle.com

Address: 4250 Congress St Ste 900 Charlotte, NORTH CAROLINA

Exchange: New York Stock Exchange

Industry: Specialty Chemicals

Albemarle Corporation Peer Analysis


A useful and more reliable way of seeing the health of a company is to compare it to other companies operating in the same sector. Below is our list of companies which we rank are the closest peers to Albemarle Corporation. If you feel that peers should be added or removed from this list please contact us. To run an in-depth peer analysis which compares many financial metrics click on the link below.

Stock Ticker Market Cap
LyondellBasell Industries N.V. LYB $31.2 Billion
Sociedad Química y Minera de Chile S.A. SQM $10.8 Billion
Ecolab Inc. ECL $71.5 Billion
PPG Industries, Inc. PPG $30.1 Billion
The Sherwin-Williams Company SHW $95.8 Billion
Air Products and Chemicals, Inc. APD $64.0 Billion
Gevo, Inc. GEVO $323.3 Million
DuPont de Nemours, Inc. DD $34.7 Billion
Linde plc LIN $224.0 Billion
Livent Corporation LTHM $3.0 Billion
Run Peer Analysis
Income Statement
Balance Sheet
Cash Flow Statement
ALB Income Statements
Quarter Year Revenue Earnings
Q2 2024 $ 1.4 Billion -$188.2 Million
Q1 2024 $ 1.4 Billion $2.4 Million
Q4 2023 $ 2.4 Billion -$617.7 Million
Q3 2023 $ 2.3 Billion $302.5 Million
Q2 2023 $ 2.4 Billion $650.0 Million
Q1 2023 $ 2.6 Billion $880.5 Million
Q4 2022 $ 2.6 Billion $839.0 Million
Q3 2022 $ 2.1 Billion $897.2 Million

View All

ALB Balance Sheets
Quarter Year Cash & Equivalents Total Assets Total Debt Total Equity
Q2 2024 $1.8 Billion $18.4 Billion $3.7 Billion $11.5 Billion
Q1 2024 $2.1 Billion $19.0 Billion $3.7 Billion $11.8 Billion
Q4 2023 $889.9 Million $18.3 Billion $4.2 Billion $9.7 Billion
Q3 2023 $1.6 Billion $18.9 Billion $3.7 Billion $10.2 Billion
Q2 2023 $1.6 Billion $19.1 Billion $3.5 Billion $9.8 Billion
Q1 2023 $1.6 Billion $17.6 Billion $3.2 Billion $9.2 Billion
Q4 2022 $1.5 Billion $15.5 Billion $3.2 Billion $8.0 Billion
Q3 2022 $1.4 Billion $13.8 Billion $3.4 Billion $7.0 Billion

View All

ALB Cash Flow Statements
Quarter Year freeCashFlow capitalExpenditure netChangeInCash
Q2 2024 -$84.7 Million -$447.6 Million -$225.6 Million
Q1 2024 -$481.4 Million -$579.3 Million $1.2 Billion
Q4 2023 -$473.5 Million $0 -$473.5 Million
Q3 2023 $83.0 Million -$545.9 Million $1.9 Million
Q2 2023 -$430.0 Million -$503.7 Million $13.0 Million
Q1 2023 $305.4 Million -$415.6 Million $87.6 Million
Q4 2022 $506.5 Million -$445.7 Million $116.3 Million
Q3 2022 $582.0 Million -$313.3 Million $452.2 Million

View All

Cookies

We use cookies to offer a better browsing experience. Cookies enhance site navigation, analyze site usage, and assist in our marketing efforts. By clicking Accept. you agree to the storing of cookies on your device. To refuse all non-required cookies, click on Decline.

Accept View Terms & Conditions